Docetaxel and Carboplatin for Patients With mCRPC and DNA-Repair Deficiencies

Clinical trial NCT02985021 · TERMINATED

Trial details

NCT number: NCT02985021
Sponsor: Seattle Institute for Biomedical and Clinical Research
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Hormone-Resistant Prostate Cancer Metastatic Prostate Carcinoma Recurrent Prostate Carcinoma Stage IV Prostate Cancer

Start date: 2016-11-01
Primary completion: 2021-04-01
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.